Virpax inks ‘patch-in-a-can’ deal for pain management

By Flora Southey contact

- Last updated on GMT

MedPharm's MedSpray 'patch-in-a-can' technology
MedPharm's MedSpray 'patch-in-a-can' technology
Virpax Pharmaceuticals has licensed MedPharm’s topical spray technology to develop a transdermal patch for non-opioid pain management products.

Under the agreement, US-based Virpax will develop an investigational spray film designed to deliver nonsteroidal anti-inflammatory drug (NSAID) DSF100 using MedPharm’s metered-dose spray, MedSpray. Financial terms were not disclosed.

The metered-dose aerosol spray – which MedPharm describes as a ‘patch-in-a-can’ – forms a thin film on the skin or mucosal membrane, enabling the transdermal delivery of NSAIDs.  

According to UK-headquartered MedPharm, the technology “features a high level of adhesiveness, accessibility and skin drying.”

In addition, “compared to a standard topical spray MedSpray gives extended release and compared to a standard patch MedSpray is invisible,” ​the spokesperson told us.

The US Food and Drug Administration granted a pre-investigational new drug meeting request for DSF100 in May this year.

Virpax is exploring other transdermal drug delivery technologies for pain management. Last month​, the US firm signed a license agreement for LipoCure’s long-active liposomal gel, to develop anaesthetics for post-operative pain.

“We believe there is an opportunity to explore the development of non-opioid transdermal pain treatments that improve on existing gel and patch products, for which adhesion and accessibility can be a challenge,”​ said Virpax CEO Anthony Mack in a statement​.

Related topics: Drug Delivery, Delivery technologies

Related news

Show more

Related products

show more

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us


View more